Cellectis (CLLS)
(Delayed Data from NSDQ)
$2.35 USD
-0.03 (-1.26%)
Updated Aug 28, 2024 12:26 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Cash flow Statements
Fiscal Year End for Cellectis SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -116.84 | -98.69 | -125.11 | -97.48 | -115.21 |
Depreciation/Amortization & Depletion | 18.52 | 18.44 | 16.57 | 9.82 | 6.88 |
Net Change from Assets/Liabilities | 48.86 | -5.72 | -4.16 | -21.83 | 11.65 |
Net Cash from Discontinued Operations | -3.64 | -18.60 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 28.35 | 17.13 | 8.14 | 29.23 | 27.54 |
Net Cash From Operating Activities | -24.75 | -87.44 | -104.56 | -80.26 | -69.14 |
Property & Equipment | -1.07 | -2.43 | -19.73 | -45.64 | -12.50 |
Acquisition/ Disposition of Subsidiaries | 0.08 | -0.45 | 0.00 | 0.00 | 0.00 |
Investments | -12.87 | 0.13 | 27.02 | -8.14 | -23.33 |
Other Investing Activities | -1.64 | -0.01 | -0.01 | -0.57 | -0.05 |
Net Cash from Investing Activities | -15.51 | -2.76 | 7.28 | -54.34 | -35.87 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 67.94 | -0.57 | 60.35 | 9.76 | -0.47 |
Issuance (Repayment) of Debt | 24.56 | 4.41 | 0.00 | 24.17 | 0.00 |
Increase (Decrease) Short-Term Debt | -11.08 | -11.01 | -12.47 | -6.61 | -3.39 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 1.45 | 8.32 | -0.36 | 0.00 | 0.00 |
Net Cash from Financing Activities | 82.87 | 1.15 | 47.53 | 27.32 | -3.86 |
Effect of Exchange Rate Changes | 0.88 | -3.36 | -5.75 | 7.91 | -2.10 |
Net Change In Cash & Equivalents | 43.49 | -92.42 | -55.51 | -99.37 | -110.98 |
Cash at Beginning of Period | 93.22 | 185.64 | 241.15 | 340.52 | 451.50 |
Cash at End of Period | 136.71 | 93.22 | 185.64 | 241.15 | 340.52 |
Diluted Net EPS | -1.77 | -2.33 | -2.55 | -1.91 | -2.41 |
Fiscal Year End for Cellectis SA falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -19.63 | 5.64 | -116.84 | -53.21 | -35.73 |
Depreciation/Amortization & Depletion | 9.30 | 4.57 | 18.52 | 13.34 | 8.88 |
Net Change from Assets/Liabilities | 52.12 | -8.89 | 48.86 | -10.18 | -10.91 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | -3.64 | -3.65 | -3.64 |
Other Operating Activities | -12.92 | -24.64 | 28.35 | -10.77 | -5.95 |
Net Cash From Operating Activities | 28.87 | -23.32 | -24.75 | -64.46 | -47.37 |
Property & Equipment | -1.26 | -0.22 | -1.07 | -0.80 | -0.48 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.08 | 0.08 | 0.08 |
Investments | -107.19 | -1.69 | -12.87 | 0.49 | 0.49 |
Other Investing Activities | -0.04 | -0.14 | -1.64 | -1.63 | -1.64 |
Net Cash from Investing Activities | -108.48 | -2.05 | -15.51 | -1.86 | -1.56 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 82.82 | 0.00 | 67.94 | 23.61 | 23.56 |
Issuance (Repayment) of Debt | 13.59 | 14.94 | 24.56 | 24.45 | 19.96 |
Increase (Decrease) Short-Term Debt | -5.62 | -2.81 | -11.08 | -8.33 | -5.55 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.39 | -0.23 | 1.45 | 1.55 | 1.63 |
Net Cash from Financing Activities | 90.41 | 11.90 | 82.87 | 41.29 | 39.60 |
Effect of Exchange Rate Changes | 1.54 | -0.27 | 0.88 | -0.82 | 0.50 |
Net Change In Cash & Equivalents | 12.33 | -13.74 | 43.49 | -25.86 | -8.83 |
Cash at Beginning of Period | 136.71 | 136.71 | 93.22 | 93.22 | 93.22 |
Cash at End of Period | 149.04 | 122.97 | 136.71 | 67.36 | 84.39 |
Diluted Net EPS | -0.28 | -0.15 | -0.69 | -0.31 | -0.19 |